KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Long-Term Debt Repayments (2016 - 2025)

Merck (MRK) has disclosed Long-Term Debt Repayments for 16 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • Quarterly Long-Term Debt Repayments fell 99.63% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 billion through Dec 2025, up 94.03% year-over-year, with the annual reading at $2.5 billion for FY2025, 94.03% up from the prior year.
  • Long-Term Debt Repayments for Q4 2025 was $2.0 million at Merck, up from $1.0 million in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $2.5 billion in Q1 2025, with the low at $1.0 million in Q4 2022.
  • Average Long-Term Debt Repayments over 5 years is $722.7 million, with a median of $645.0 million recorded in 2024.
  • The sharpest move saw Long-Term Debt Repayments tumbled 99.92% in 2023, then surged 75000.0% in 2024.
  • Over 5 years, Long-Term Debt Repayments stood at $1.2 billion in 2021, then crashed by 99.91% to $1.0 million in 2022, then soared by 200.0% to $3.0 million in 2023, then surged by 17866.67% to $539.0 million in 2024, then tumbled by 99.63% to $2.0 million in 2025.
  • According to Business Quant data, Long-Term Debt Repayments over the past three periods came in at $2.0 million, $1.0 million, and $2.5 billion for Q4 2025, Q3 2025, and Q1 2025 respectively.